Benzinga | Aug 10, 2020 08:20AM EDT

BioSpecifics Technologies Q2 EPS $0.11 Beats $(0.05) Estimate, Sales $3.90M Beat $2.06M Estimate

BioSpecifics Technologies (NASDAQ:BSTC) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $(0.05) by 320 percent. This is a 87.36 percent decrease over earnings of $0.87 per share from the same period last year. The company reported quarterly sales of $3.90 million which beat the analyst consensus estimate of $2.06 million by 89.32 percent. This is a 55.95 percent decrease over sales of $8.85 million the same period last year.